- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06707792
Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients
November 27, 2024 updated by: Merve Firat, Hacettepe University
Investigation of Validity and Reliability of 6 Minute Stepper Test in Kidney Transplant Recipients
The aim of our study was to investigate the validity and reliability of the 6 minute stepper test in kidney transplant recipients.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Merve Firat
- Phone Number: +90 850 441 02 44
- Email: mervefirat@ahievran.edu.tr
Study Contact Backup
- Name: Naciye Vardar-Yagli
- Phone Number: +903123051576
- Email: naciyevardar@yahoo.com
Study Locations
-
-
-
Ankara, Turkey
- Recruiting
- Hacettepe University
-
Contact:
- Naciye Vardar-Yagli, Assistant Professor
- Email: naciyevardar@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Kidney transplant recipients will be included.
Description
Inclusion Criteria:
- Patients with kidney transplantation
- At least 6 months after the kidney transplant
- Not having regular exercise habits
- Voluntary participation in the study
Exclusion Criteria:
- Having a musculoskeletal problem that may interfere with the tests
- Having neurological impairment
- Having chronic lung disease
- Having had any cardiovascular event in the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Kidney transplant recipients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise capacity
Time Frame: Day 1
|
Exercise capacity will be assessed with a 6 minute stepper test.
|
Day 1
|
|
Exercise capacity
Time Frame: Day 1
|
Exercise capacity will be assessed with a 6 minute walk test.
|
Day 1
|
|
Peripheral muscle strength
Time Frame: Day 1
|
Knee extensor strength will be measured using a portable portable handheld dynamometer.
|
Day 1
|
|
Lower extremity endurance
Time Frame: Day 1
|
It will be evaluated with a one-minute sit to stand test.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 9, 2024
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
November 25, 2024
First Submitted That Met QC Criteria
November 25, 2024
First Posted (Actual)
November 27, 2024
Study Record Updates
Last Update Posted (Estimated)
December 2, 2024
Last Update Submitted That Met QC Criteria
November 27, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- GO 23/604
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Transplanted Recipients
-
Novartis PharmaceuticalsCompletedRenal Transplanted RecipientsAustralia
-
Seoul National University HospitalActive, not recruitingRenal Transplanted Recipients | Kidney FunctionKorea, Republic of
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingPediatric Liver Transplanted RecipientsUnited States
-
Cliniques universitaires Saint-Luc- Université...CompletedHealthy Donors | Pediatric Liver Transplanted Recipients
-
Astellas Pharma China, Inc.CompletedRenal Transplant RecipientsChina
-
Georgetown UniversityTerminatedRenal Transplant RecipientsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedRenal Allograft Recipients
-
Agency for Healthcare Research and Quality (AHRQ)Unknown
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)TerminatedRenal Transplant RecipientsUnited States
-
Montefiore Medical CenterTerminated